Sol-Gel Q1 Revenue Misses Expectations by 90%, Reports $100K Sales and $3.7M Loss
SLGL has more than doubled off its 52-week low of $6.8.
Summary
Sol-Gel Technologies reported Q1 revenue of $100,000 and a net loss of $3.7 million. This revenue figure is a significant miss compared to the $900,000 Reuters had previously expected. While the short-term commercial performance is weaker than anticipated, this earnings report coincides with a highly positive 6-K filing announcing a patent extension for SGT-610 until 2044 and funding secured into 2028, which provides strong long-term positive context.
At the time of this announcement, SLGL was trading at $71.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $241.3M. The 52-week trading range was $6.80 to $97.97. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.